655 related articles for article (PubMed ID: 19005406)
21. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
Kovac D; Kotnik V; Kandus A
Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
[TBL] [Abstract][Full Text] [Related]
22. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.
Keown P; Balshaw R; Khorasheh S; Chong M; Marra C; Kalo Z; Korn A
BioDrugs; 2003; 17(4):271-9. PubMed ID: 12899644
[TBL] [Abstract][Full Text] [Related]
24. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.
Mourad G; Rostaing L; Legendre C; Garrigue V; Thervet E; Durand D
Transplantation; 2004 Aug; 78(4):584-90. PubMed ID: 15446319
[TBL] [Abstract][Full Text] [Related]
25. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
Kahan BD; Rajagopalan PR; Hall M
Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
[TBL] [Abstract][Full Text] [Related]
26. Induction with basiliximab in renal transplantation.
Ferrer F; Machado S; Alves R; Macário F; Bastos C; Roseiro A; Mota A
Transplant Proc; 2010 Mar; 42(2):467-70. PubMed ID: 20304166
[TBL] [Abstract][Full Text] [Related]
27. A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients.
Offner G; Broyer M; Niaudet P; Loirat C; Mentser M; Lemire J; Crocker JF; Cochat P; Clark G; Chodoff L; Korn A; Hall M
Transplantation; 2002 Oct; 74(7):961-6. PubMed ID: 12394837
[TBL] [Abstract][Full Text] [Related]
28. Induction immunosuppressive therapy in renal transplantation: does basiliximab make the difference?
Jorge S; Guerra J; Silva S; Santana A; Mil-Homens C; Prata MM
Transplant Proc; 2008 Apr; 40(3):693-6. PubMed ID: 18454989
[TBL] [Abstract][Full Text] [Related]
29. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
30. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.
Höcker B; Kovarik JM; Daniel V; Opelz G; Fehrenbach H; Holder M; Hoppe B; Hoyer P; Jungraithmayr TC; Köpf-Shakib S; Laube GF; Müller-Wiefel DE; Offner G; Plank C; Schröder M; Weber LT; Zimmerhackl LB; Tönshoff B
Transplantation; 2008 Nov; 86(9):1234-40. PubMed ID: 19005405
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.
Höcker B; Weber LT; Bunchman T; Rashford M; Tönshoff B;
Pediatr Transplant; 2005 Aug; 9(4):504-11. PubMed ID: 16048604
[TBL] [Abstract][Full Text] [Related]
33. Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
Cibrik D; Meier-Kriesche HU; Bresnahan B; Wu YM; Klintmalm G; Kew CE; Kuo PC; Whelchel J; Cohen D; Baliga P; Akalin E; Benedetti E; Wright F; Lieberman B; Ulbricht B; Jensik S;
Clin Transplant; 2007; 21(2):192-201. PubMed ID: 17425744
[TBL] [Abstract][Full Text] [Related]
34. Effect of basiliximab on renal allograft rejection within 1 year after transplantation.
Lee BM; Oh CK; Jin SH; Kim JH; Kim SJ; Kim H; Shin GT
Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function.
Andrés A; Marcén R; Valdés F; Plumed JS; Solà R; Errasti P; Lauzurica R; Pallardó L; Bustamante J; Amenábar JJ; Plaza JJ; Gómez E; Grinyó JM; Rengel M; Puig JM; Sanz A; Asensio C; Andrés I;
Clin Transplant; 2009; 23(1):23-32. PubMed ID: 18798851
[TBL] [Abstract][Full Text] [Related]
36. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
[TBL] [Abstract][Full Text] [Related]
37. Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.
Filipponi F; Callea F; Salizzoni M; Grazi GL; Fassati LR; Rossi M; Risaliti A; Burra P; Agnes S; De Carlis L; Valente U; Ferrara R; Pisati R
Transplantation; 2004 Nov; 78(10):1488-95. PubMed ID: 15599313
[TBL] [Abstract][Full Text] [Related]
38. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.
Neuhaus P; Clavien PA; Kittur D; Salizzoni M; Rimola A; Abeywickrama K; Ortmann E; Chodoff L; Hall M; Korn A; Nashan B;
Liver Transpl; 2002 Feb; 8(2):132-42. PubMed ID: 11862589
[TBL] [Abstract][Full Text] [Related]
39. Two-dose basiliximab compared with two-dose daclizumab in renal transplantation: a clinical study.
Lin M; Ming A; Zhao M
Clin Transplant; 2006; 20(3):325-9. PubMed ID: 16824149
[TBL] [Abstract][Full Text] [Related]
40. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
